삼성서울병원

Ko En

Park, Keun Chil M.D

TITLE
Professor, Div of Hematology-Oncology
Treament Schedule 04 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
AM
PM
Treament Schedule 05 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
SUN
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Visiting Associate National Cancer Institute(NCI), NIH, USA

Clinical & Research Interests

Lung Cancer
Head and Neck Cancer
Esophageal Cancer

Participation in Academic Societies
and Research

Korean Medical Association (KMA)
The Korean Association of Internal Medicine (KAIM)
Korean Cancer Association(KCA)
American Society of Clinical Oncology (ASCO)
American Association for Cancer Research (AACR)
European Society of Medical Oncology (ESMO)
International Association for the Study of Lung Cancer (IASLC)
Korean Association for Clinical Oncology (KACO)

Selected Publications

  • J THORAC ONCOL 2019 10.1016/j.jtho.2019.10.010 In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing Park1, S; Lee, SH; Park, K
    View PubMed
  • LANCET ONCOL 2019 10.1016/S1470-2045(19)30634-5 Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial Nakagawa1, K; Garon, EB; Seto, T; Nishio, M; Aix, SP; Paz-Ares, L; Chiu, CH; Park, K; Novello, S; Nadal, E; Imamura, F; Yoh, K; Shih, JY; Au, KH; Moro-Sibilot, D; Enatsu, S; Zimmermann, A; Frimodt-Moller, B; Visseren-Grul, C; Reck, M
    View PubMed
  • INT J CANCER 2019 10.1002/ijc.32235 Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease Shin1, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH
    View PubMed
  • EUR J CANCER 2019 10.1016/j.ejca.2019.08.001 Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing Kim1, HS; Cha, H; Kim, JH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2019 10.3904/kjim.2017.234 Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck Kim1, MJ; Kim, SM; Jung, HA; Hong, JY; Chang, WJ; Choi, MK; Kim, HS; Sun, JM; Park, K; Ahn, MJ
    View PubMed